Bioactivation mechanisms of N‐hydroxyaristolactams: Nitroreduction metabolites of aristolochic acids
Open Access
- 2 August 2019
- journal article
- research article
- Published by Wiley in Environmental and Molecular Mutagenesis
- Vol. 60 (9) , 792-806
Abstract
Aristolochic acids (AAs) are human nephrotoxins and carcinogens found in concoctions of Aristolochia plants used in traditional medicinal practices worldwide. Genotoxicity of AAs is associated with the formation of active species catalyzed by metabolic enzymes, the full repertoire of which is unknown. Recently, we provided evidence that sulfonation is important for bioactivation of AAs. Here, we employ Salmonella typhimurium umu tester strains expressing human N-acetyltransferases (NATs) and sulfotransferases (SULTs), to study the role of conjugation reactions in the genotoxicities of N-hydroxyaristolactams (AL-I-NOH and AL-II-NOH), metabolites of AA-I and AA-II. Both N-hydroxyaristolactams show stronger genotoxic effects in umu strains expressing human NAT1 and NAT2, than in the parent strain. Additionally, AL-I-NOH displays increased genotoxicity in strains expressing human SULT1A1 and SULT1A2, whereas AL-II-NOH shows enhanced genotoxicity in SULT1A1/2 and SULT1A3 strains. 2,6-Dichloro-4-nitrophenol, SULTs inhibitor, reduced umuC gene expression induced by N-hydroxyaristolactams in SULT1A2 strain. N-hydroxyaristolactams are also mutagenic in parent strains, suggesting that an additional mechanism(s) may contribute to their genotoxicities. Accordingly, using putative SULT substrates and inhibitors, we found that cytosols obtained from human kidney HK-2 cells activate N-hydroxyaristolactams in aristolactam-DNA adducts with the limited involvement of SULTs. Removal of low-molecular-weight reactants in the 3.5–10 kDa range inhibits the formation of aristolactam-DNA by 500-fold, which could not be prevented by the addition of cofactors for SULTs and NATs. In conclusion, our results demonstrate that the genotoxicities of N-hydroxyaristolactams depend on the cell type and involve not only sulfonation but also N,O-acetyltransfer and an additional yet unknown mechanism(s). Environ. Mol. Mutagen. 2019.Keywords
This publication has 81 references indexed in Scilit:
- Aristolochic acid-associated urothelial cancer in TaiwanProceedings of the National Academy of Sciences, 2012
- Lack of recognition by global-genome nucleotide excision repair accounts for the high mutagenicity and persistence of aristolactam-DNA adductsNucleic Acids Research, 2011
- Identification of a Reduction Product of Aristolochic Acid: Implications for the Metabolic Activation of Carcinogenic Aristolochic AcidJournal of Natural Products, 2010
- DNA adducts of aristolochic acid II: total synthesis and site-specific mutagenesis studies in mammalian cellsNucleic Acids Research, 2009
- Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003Chinese Medicine, 2008
- Aristolochic acid and the etiology of endemic (Balkan) nephropathyProceedings of the National Academy of Sciences, 2007
- Human sulphotransferases are involved in the activation of aristolochic acids and are expressed in renal target tissueInternational Journal of Cancer, 2005
- Role of human N-acetyltransferases, NAT1 or NAT2, in genotoxicity of nitroarenes and aromatic amines in Salmonella typhimurium NM6001 and NM6002Carcinogenesis, 1999
- HK-2: An immortalized proximal tubule epithelial cell line from normal adult human kidneyKidney International, 1994
- Mutagenicity of the two main components of commercially available carcinogenic aristolochic acid in Salmonella typhimuriumCancer Letters, 1984